Hostname: page-component-8448b6f56d-tj2md Total loading time: 0 Render date: 2024-04-24T17:20:37.608Z Has data issue: false hasContentIssue false
  • English
  • Français

Outbreak of Fluoroquinolone-Resistant Escherichia coli Infections after Transrectal Ultrasound—Guided Biopsy of the Prostate

Published online by Cambridge University Press:  02 January 2015

Donald Dumford III ,
Nuntra Suwantarat ,
Vineet Bhasker ,
Sirisha Kundrapu ,
Trina F. Zabarsky ,
Paul Drawz ,
Hui Zhu  and
Curtis J. Donskey
Donald Dumford III*
Affiliation:
Department of Infectious Diseases, University Hospitals of Cleveland, Cleveland, Ohio
Nuntra Suwantarat
Affiliation:
Department of Infectious Diseases, University Hospitals of Cleveland, Cleveland, Ohio
Vineet Bhasker
Affiliation:
Department of Infectious Diseases, University Hospitals of Cleveland, Cleveland, Ohio
Sirisha Kundrapu
Affiliation:
Case Western Reserve University School of Medicine, Cleveland, Ohio
Trina F. Zabarsky
Affiliation:
Infection Control Department, Cleveland Veterans Affairs Medical Center, Cleveland, Ohio
Paul Drawz
Affiliation:
Case Western Reserve University School of Medicine, Cleveland, Ohio
Hui Zhu
Affiliation:
Case Western Reserve University School of Medicine, Cleveland, Ohio Urology Section, Cleveland Veterans Affairs Medical Center, Cleveland, Ohio
Curtis J. Donskey
Affiliation:
Case Western Reserve University School of Medicine, Cleveland, Ohio Geriatric Research, Education, and Clinical Center, Cleveland Veterans Affairs Medical Center, Cleveland, Ohio
*
Geriatric Research, Education, and Clinical Center 1110W, Cleveland Veterans Affairs Medical Center, 10701 East Boulevard, Cleveland, OH 44106 (curtisdl23@yahoo.com)
Get access Rights & Permissions [Opens in a new window]

Abstract

Design.

We conducted an investigation after identifying a cluster of 4 serious infections following transrectal ultrasound–guided biopsy of the prostate (TRUBP) during a 2-month period.

Setting.

veterans Affairs medical center.

Patients.

Patients with urinary tract infection (UTI) after TRUBP and time-matched controls with no evidence of infection.

Methods.

The incidence of UTI within 30 days after TRUBP was calculated from 2002 through 2010. We evaluated the correlation between infection with fluoroquinolone-resistant gram-negative bacilli (GNB) and fluoroquinolone resistance in outpatient Escherichia coli urinary isolates and performed a case-control study to determine risk factors for infection with fluoroquinolone-resistant GNB. Processes for TRUBP prophylaxis, procedures, and equipment sterilization were reviewed.

Results.

An outbreak of UTI due to fluoroquinolone-resistant E. coli after TRUBP began 2 years before the cluster was identified and was correlated with increasing fluoroquinolone resistance in outpatient E. coli. No deficiencies were identified in equipment processing or biopsy procedures. Fluoroquinolone-resistant E. coli UTI after TRUBP was independently associated with prior infection with fluoroquinolone-resistant GNB (adjusted odds ratio, 20.8; P = .005). A prediction rule including prior UTI, hospitalization in the past year, and previous infection with fluoroquinolone-resistant GNB identified only 17 (49%) of 35 cases.

Conclusions.

The outbreak of fluoroquinolone-resistant E. coli infections after TRUBP closely paralleled rising rates of fluoroquinolone resistance among outpatient E. coli isolates. The delayed detection of the outbreak and the absence of sensitive predictors of infection suggest that active surveillance for infection after TRUBP is necessary in the context of increasing fluoroquinolone resistance in the United States.

Type
Original Article
Information
Infection Control & Hospital Epidemiology , Volume 34 , Issue 3 , March 2013 , pp. 269 - 273
Copyright
Copyright © The Society for Healthcare Epidemiology of America 2013

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

1. Loeb, S, Carter, HB, Brendt, SI, Ricker, W, Shaeffer, EM. Complications after prostate biopsy: data from SEER-Medicine. J Urol 2011;186:1830–1834.CrossRefGoogle Scholar
2. Gillespie, J, Arnold, KE, Kainer, MA, et al. Pseudomonas aeruginosa infections associated with transrectal ultrasound-guided prostate biopsies—Georgia, 2005. MMWR Morb Mortal Wkly Rep 2006;55:776–777.Google Scholar
3. Rietbergen, JBW, Boeken Krufer, AE, Kranse, R, Schroder, FH. Complications of transrectal ultrasound-guided systemic sextant biopsies of the prostate: evaluation of complication rates and risk factors within a population-based screening program. Urology 1997;49:875–880.Google Scholar
4. Otrock, ZK, Oghlakian, GO, Salamoun, MM, Haddad, M, Bizri, ARN. Incidence of urinary tract infection following transrectal ultrasound guided prostate biopsy at a tertiary-care medical center in Lebanon. Infect Control Hosp Epidemiol 2004;25:873–877.Google Scholar
5. Shigemura, K, Miyagi, T, Nakashima, T, Shimamura, M. Acute bacterial prostatitis after transrectal prostate needle biopsy: clinical analysis. J Infect Chemother 2008;14:40–43.Google Scholar
6. Kim, SJ, Kim, SI, Ahn, HS, Choi, JB, Kim, YS, Kim, SJ. Risk factors for acute prostatitis after transrectal biopsy of the prostate. Korean J Urol 2010;51:426–430.Google Scholar
7. Hadway, P, Barrett, LK, Waghorn, DJ, et al. Urosepsis and bacteremia caused by antibiotic-resistant organisms after transrectal ultrasonography-guided prostate biopsy. BJU Int 2009; 104:1556–1558.Google Scholar
8. Zaytoun, OM, Vargo, EN, Rajan, R, Berglund, R, Gordon, S, Jones, JS. Emergence of fluoroquinolone-resistant Escherichia coli as cause of postprostate biopsy infection: implications for prophylaxis and treatment. Urology 2011;77:1035–1042.Google Scholar
9. Mosharafa, AA, Torky, MH, El Said, WM, Meshref, A. Rising incidence of acute prostatitis following prostate biopsy: fluoroquinolone resistance and exposure is a significant risk factor. Urology 2011;78:511–514.Google Scholar
10. Hedelin, H, Claesson, BE, Wilpart, A. Febrile reactions after transrectal ultrasound-guided prostatic biopsy: a retrospective study. Scand J Urol Nephrol 2011;45:393–396.Google Scholar
11. Zani, EL, Clark, OA, Rodrigues Netto, N Jr. Antibiotic prophylaxis for transrectal prostate biopsy. Cochrane Database Syst Rev 2011; 11:CD006576.Google Scholar
12. Wolf, JS Jr, Bennett, CJ, Dmochowski, RR, Hollenbeck, BK, Pearle, MS, Shaeffer, AJ; Urologie Surgery Antimicrobial Prophylaxis Best Practice Policy Panel. Best practice policy statement on urologie surgery antimicrobial prophylaxis. J Urol 2008; 179: 1379–1390.Google Scholar
13. Johnson, L, Sabel, A, Burman, WJ, et al. Emergence of fluoro-quinone resistance in outpatient urinary Escherichia coli isolates. Am f Med 2008;121:876–884.Google Scholar
14. Feliciano, J, Teper, E, Ferrandino, M, et al. The incidence of fluoroquinolone resistant infections after prostate biopsy—are fluoroquinolones still effective prophylaxis? J Urol 2008; 179:952–955.Google Scholar
15. Young, JL, Liss, MA, Szabo, RJ. Sepsis due to fluoroquinolone-resistant Escherichia coli after transrectal ultrasound-guided prostate needle biopsy. Urology 2009;74:332–339.Google Scholar
16. Nam, RK, Saskin, R, Lee, Y, et al. Increasing hospital admission rates for urological complications after transrectal ultrasound guided prostate biopsy. J Urol 2010;183:963–968.Google Scholar
17. Liss, MA, Chang, A, Santos, R, et al. Prevalence and significance of fluoroquinolone resistant Escherichia coli in patients undergoing transrectal ultrasound guided prostate needle biopsy. J Urol 2011;185:1283–1288.Google Scholar
18. Ho, HS, Ng, LG, Tan, YH, Yeo, M, Cheng, CW. Intramuscular gentamicin improves the efficacy of ciprofloxacin as an antibiotic prophylaxis for transrectal prostate biopsy. Ann Acad Med Singapore 2009;38:212–216.Google Scholar
19. Madden, T, Doble, A, Aliyu, SH, Neal, DE. Infective complications after transrectal ultrasound-guided prostate biopsy following a new protocol for antibiotic prophylaxis aimed at reducing hospital-acquired infections. BJU Int 2011;108:1597–1602.Google Scholar
20. Hori, S, Sengupta, A, Joannides, A, Balogun-Ojuri, B, Tilley, R, McLoughlin, J. Changing antibiotic prophylaxis for transrectal ultrasound-guided prostate biopsies: are we putting our patients at risk? BJU Int 2010;106:1298–1302.Google Scholar
21. Fraschini, F, Scaglione, F, Falchi, M, et al. Pharmacokinetics and tissue distribution of amoxicillin plus clavulanic acid after oral administration in man. J Chemother 1999;2:171–177.Google Scholar
22. Batura, D, Rao, GG, Nielsen, PB. Prevalence of antimicrobial resistance in intestinal flora of patients undergoing prostatic biopsy: implications for prophylaxis and treatment of infections after biopsy. BJU Int 2010;106:1017–1020.Google Scholar
23. Taylor, AK, Zembower, TR, Nadler, RB, et al. Targeted antimicrobial prophylaxis using rectal swab cultures in men undergoing transrectal ultrasound guided prostate biopsy is associated with reduced incidence of postoperative infectious complications and cost of care. J Urol 2012;187:1275–1279.Google Scholar